Rithm Capital Corp
SWB:14N1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
R
|
Rithm Capital Corp
SWB:14N1
|
US |
|
H
|
Hisamitsu Pharmaceutical Co Inc
OTC:HTSUF
|
JP |
|
Twist Bioscience Corp
NASDAQ:TWST
|
US |
Wall St Price Targets
14N1 Price Targets Summary
Rithm Capital Corp
According to Wall Street analysts, the average 1-year price target for 14N1 is 11.76 EUR with a low forecast of 10.94 EUR and a high forecast of 13.19 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 14N1's stock price target?
Price Target
11.76
EUR
According to Wall Street analysts, the average 1-year price target for 14N1 is 11.76 EUR with a low forecast of 10.94 EUR and a high forecast of 13.19 EUR.
What is the Revenue forecast for Rithm Capital Corp?
Projected CAGR
-21%
Over the last 12 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is -21%.
What is the Operating Income forecast for Rithm Capital Corp?
Projected CAGR
28%
Over the last 12 years, the compound annual growth rate for Operating Income has been 9%. The projected CAGR for the next 2 years is 28%.
What is the Net Income forecast for Rithm Capital Corp?
Projected CAGR
36%
Over the last 12 years, the compound annual growth rate for Net Income has been 7%. The projected CAGR for the next 3 years is 36%.
